Skip to main content
All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for CENCORA, INC. · Pharmaceutical wholesale distribution company

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · Senate · $60,000.00 income · posted Jan 15, 2026

Official filing document

 Lobbying activity 2
Health Issues

IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).

Pharmacy

Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem